ABVC BioPharma (ABVC) vs Rockwell Medical (RMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Rockwell Medical (RMTI) has outperformed ABVC BioPharma (ABVC) over the past year, losing 34.6% versus a loss of 67.8%. Over five years, RMTI leads with a -88.0% price change compared with -97.3% for ABVC. ABVC BioPharma is the larger company by market cap ($23.4 million vs $23.1 million), about 1.0 times the size, while Rockwell Medical is growing revenue faster (-31.8% vs -41.9%).
Rockwell Medical converts more of its revenue into profit, with a net margin of -7.7% versus -2671.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABVC | RMTI |
|---|---|---|
| Share price | $0.8663 | $5.82 |
| Market cap | $23.37M | $23.12M |
| 1-day change | -1.56% | -7.03% |
| YTD return | -59.33% | -29.88% |
| 1-year return | -67.80% | -34.61% |
| 5-year return | -97.29% | -87.98% |
| Forward P/E | — | 83.14 |
| EPS (TTM) | $-0.20 | $-1.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $296.00K | $69.26M |
| Revenue growth (YoY) | -41.91% | -31.76% |
| Net income (latest FY) | $-7.91M | $-5.31M |
| Gross margin | — | 16.89% |
| Operating margin | -2415.97% | -6.77% |
| Net margin | -2671.81% | -7.67% |
| 52-week high | $2.87 | $12.90 |
| 52-week low | $0.707 | $4.89 |
| Distance from 52-week high | -69.82% | -54.88% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +243.64% |
| Average volume | 81.92K | 25.91K |
| Shares outstanding | 26.98M | 3.97M |
| Employees | 16 | 157 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RMTI has outperformed ABVC by 33.2 percentage points over the past year.
- Rockwell Medical is more profitable, keeping -7.7 cents of every revenue dollar as net income versus -2671.8 cents for ABVC BioPharma.
- Rockwell Medical grew revenue faster in its latest fiscal year (-31.76% vs -41.91%).
About ABVC BioPharma
ABVC stock →ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients.
Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees
About Rockwell Medical
RMTI stock →Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.
Health Care · Biotechnology: Pharmaceutical Preparations · 157 employees
ABVC vs RMTI FAQ
Which is bigger, ABVC BioPharma or Rockwell Medical?
ABVC BioPharma (ABVC) is larger, with a market capitalization of $23.37M compared with $23.12M for Rockwell Medical (RMTI).
Which stock has performed better over the past year, ABVC or RMTI?
RMTI returned -34.61% over the past 12 months, compared with -67.80% for ABVC (price return, excluding dividends). Past performance does not predict future results.
Are ABVC BioPharma and Rockwell Medical in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.